In a previous post I discussed the importance
of studying Babesia microti. One of the reasons is that it has the same
vector, Ixodid ticks, as the parasite Borrelia
burgdorferi, which causes Lyme disease.
Ten percent of patients, in the United States, infected with Borrelia burgdorferi are also co-infected
with Babesia microti (Shoemaker et al., 2006). The number of individuals
with co-infections is still on the rise. The double infection of the two parasites can
cause more severe and persistent symptoms.
Patients with co-infections showed resistance to the drugs Azithromycin
and Atovaquone, which are normally used to treat these parasitic infections (Shoemaker
et al., 2006). Other problems with the previous drugs of
choice were that it did not relieve post Lyme disease syndrome (PLS) symptoms. PLS is a set of symptoms that arise after
Lyme disease has been treated. It is
most likely due to a neurotoxin released by the parasite B. burgdorferi. It is
believed that Babesia microti may
also release a similar neurotoxin (Shoemaker et al., 2006).
An
experiment was preformed in order to find the most effective drug for treating
co-infections of B. microti and B. burgdorferi. The results showed that a treatment of atovaquone
plus cholestyramine over a 9-week period
is necessary to relieve the symptoms of both infections (Shoemaker et al., 2006). The drug cholestyramine was also effective in
relieving PLS symptoms in majority of the patients. This is most likely due to the ability of
cholestyramine to bind to the neurotoxins secreted by B. burgdorferi. Once
cholestyramine binds to the neurotoxin it can be excreted through the
feces. The reason previous drugs were
less effective at relieving PSD symptoms is because although they would kill
the parasites B. microti and B. burgdorferi they would leave the
neurotoxins in the host’s blood stream (Shoemaker et al., 2006).
The reason
I chose this article was because in my previous article I discussed methods of
detecting Babesia microti. I wanted to write a post about
treatments for those who have been infected with the disease. In my first blog post I also talked about how
individuals can often be infected by Babesia
microti and Borrelia burgdorferi
at the same time. This article discussed
effective methods of individuals who have been co-infected with both
parasites. Since there has been an
increase in the number of cases were the two parasites are being transmitted
together, it is beneficial to have a drug that responds to both.
References
Shoemaker, R.C., Hudnell, K.H., House, D.D., Kempen, A.D.,
Pakes, G.E. 2006. Atovaquone
Plus
Cholestrymine in Patients Coinfected With Babesia
microti and Borrelia burgdorferi
Refractory to Other
Treatment. Advances in Therapy.23 (1):1-11